My Quote Request
No products added yet
6505-01-172-1147
20 Products
NDC00024-0304-06
DANAZOL CAPSULES,USP
NSN, MFG P/N
6505011721147
NSN
6505-01-172-1147
NDC00024-0304-06
DANAZOL CAPSULES,USP
NSN, MFG P/N
6505011721147
NSN
6505-01-172-1147
MFG
SANOFI INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DANAZOL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DANAZOL CAPSULES USP 100MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NESACAINE INJECTION
CHLOROPROCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011715259
NSN
6505-01-171-5259
NESACAINE INJECTION
CHLOROPROCAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505011715259
NSN
6505-01-171-5259
MFG
PENNWALT CORP RX DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CHLOROPROCAINE HYDROCHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLOROPROCAINE HYDROCHLORIDE INJECTION USP 10MG/ML 30ML VIAL
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ASTRA PHARMACEUTICAL PRODUCTS INC
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE-DOSE VIAL; WITH PRESERVATIVE AND BUFFER
Related Searches:
NDC00003-1309-01
YELLOW FEVER VACCINE,USP
NSN, MFG P/N
6505011715260
NSN
6505-01-171-5260
NDC00003-1309-01
YELLOW FEVER VACCINE,USP
NSN, MFG P/N
6505011715260
NSN
6505-01-171-5260
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
DILUTING AGENT: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: YELLOW FEVER VACCINE USP 5 SINGLE DOSE VIALS
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
QUANTITY WITHIN EACH UNIT PACKAGE: 1.0 DOSES
SPECIAL FEATURES: A/A DILUTING AGENT; PACKAGED TOGETHER WITH A SEPARATE BOX OF 5 DILUENTS
UNIT PACKAGE QUANTITY: 5
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC49281-0915-01
YELLOW FEVER VACCINE,USP
NSN, MFG P/N
6505011715260
NSN
6505-01-171-5260
NDC49281-0915-01
YELLOW FEVER VACCINE,USP
NSN, MFG P/N
6505011715260
NSN
6505-01-171-5260
MFG
SANOFI PASTEUR INC.
Description
DILUTING AGENT: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: YELLOW FEVER VACCINE USP 5 SINGLE DOSE VIALS
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
QUANTITY WITHIN EACH UNIT PACKAGE: 1.0 DOSES
SPECIAL FEATURES: A/A DILUTING AGENT; PACKAGED TOGETHER WITH A SEPARATE BOX OF 5 DILUENTS
UNIT PACKAGE QUANTITY: 5
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC17317-0171-01
FERRIC SUBSULFATE SOLUTION,USP
NSN, MFG P/N
6505011715792
NSN
6505-01-171-5792
NDC17317-0171-01
FERRIC SUBSULFATE SOLUTION,USP
NSN, MFG P/N
6505011715792
NSN
6505-01-171-5792
MFG
AMEND DRUG AND CHEMICAL CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 480.000 MILLILITERS FERRIC SUBSULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 480.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CEPACOL ANESTHETIC TROCHES
CETYLPYRIDINIUM CHLORIDE AND BENZOCAINE LOZENGES
NSN, MFG P/N
6505011716051
NSN
6505-01-171-6051
CEPACOL ANESTHETIC TROCHES
CETYLPYRIDINIUM CHLORIDE AND BENZOCAINE LOZENGES
NSN, MFG P/N
6505011716051
NSN
6505-01-171-6051
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS BENZOCAINE ACTIVE INGREDIENT AND 1.500 MILLIGRAMS CETYLPYRIDINIUM CHLORIDE ACTIVE INGREDIENT
DESIGN CONTROL REFERENCE: NDC00068-0213-15
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CETYLPYRIDINIUM CHLORIDE AND BENZOCAINE LOZENGES 324S
MANUFACTURERS CODE: 93544
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 324 LOZENGES PER PACKAGE
THE MANUFACTURERS DATA:
Related Searches:
NDC00068-0213-15
CETYLPYRIDINIUM CHLORIDE AND BENZOCAINE LOZENGES
NSN, MFG P/N
6505011716051
NSN
6505-01-171-6051
NDC00068-0213-15
CETYLPYRIDINIUM CHLORIDE AND BENZOCAINE LOZENGES
NSN, MFG P/N
6505011716051
NSN
6505-01-171-6051
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS BENZOCAINE ACTIVE INGREDIENT AND 1.500 MILLIGRAMS CETYLPYRIDINIUM CHLORIDE ACTIVE INGREDIENT
DESIGN CONTROL REFERENCE: NDC00068-0213-15
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CETYLPYRIDINIUM CHLORIDE AND BENZOCAINE LOZENGES 324S
MANUFACTURERS CODE: 93544
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 324 LOZENGES PER PACKAGE
THE MANUFACTURERS DATA:
Related Searches:
2B1474
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011716801
NSN
6505-01-171-6801
2B1474
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011716801
NSN
6505-01-171-6801
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.150 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.330 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BAXTER HEALTHCARE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: FLEXIBLE PLASTIC BAG WITH 2 ATTACHED OUTLET POSTS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00338-0603-04
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011716801
NSN
6505-01-171-6801
NDC00338-0603-04
DEXTROSE,POTASSIUM CHLORIDE,AND SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011716801
NSN
6505-01-171-6801
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.150 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.330 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BAXTER HEALTHCARE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: FLEXIBLE PLASTIC BAG WITH 2 ATTACHED OUTLET POSTS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
08-4402
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011716802
NSN
6505-01-171-6802
08-4402
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011716802
NSN
6505-01-171-6802
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS ACETATE PER LITER AND 30.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM PER LITER AND 105.750 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM
PRIMARY CONTAINER CONTENT QUANTITY: 3.430 LITERS OR 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PACK AKJA ARE THE IONIC CONTENT OF THE ACID,WHEN COMBINED WITH NATURALYTE 4400 DRY PACK (1 PART SOLUTION DILUTES WITH 44 PARTS WATER); USED IN COBE BICARBONATE PROPORTIONING SYSTEM
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 130.000 MILLIEQUIVALENTS SODIUM PER LITER
Related Searches:
08-4402-7
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011716802
NSN
6505-01-171-6802
08-4402-7
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011716802
NSN
6505-01-171-6802
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS ACETATE PER LITER AND 30.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM PER LITER AND 105.750 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM
PRIMARY CONTAINER CONTENT QUANTITY: 3.430 LITERS OR 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PACK AKJA ARE THE IONIC CONTENT OF THE ACID,WHEN COMBINED WITH NATURALYTE 4400 DRY PACK (1 PART SOLUTION DILUTES WITH 44 PARTS WATER); USED IN COBE BICARBONATE PROPORTIONING SYSTEM
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 130.000 MILLIEQUIVALENTS SODIUM PER LITER
Related Searches:
NATURALYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011716802
NSN
6505-01-171-6802
NATURALYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011716802
NSN
6505-01-171-6802
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS ACETATE PER LITER AND 30.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM PER LITER AND 105.750 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM
PRIMARY CONTAINER CONTENT QUANTITY: 3.430 LITERS OR 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PACK AKJA ARE THE IONIC CONTENT OF THE ACID,WHEN COMBINED WITH NATURALYTE 4400 DRY PACK (1 PART SOLUTION DILUTES WITH 44 PARTS WATER); USED IN COBE BICARBONATE PROPORTIONING SYSTEM
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: PER LITER AND 2.000 MILLIEQUIVALENTS POTASSIUM PER LITER AND 130.000 MILLIEQUIVALENTS SODIUM PER LITER
Related Searches:
NDC00013-8555-80
XYLOSE,USP
NSN, MFG P/N
6505011717493
NSN
6505-01-171-7493
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 25 MG.; POWDER; ORAL; SOLUBLE; FOR RECONSTITUTION IN WATER
Related Searches:
XYLO-PFAN
XYLOSE,USP
NSN, MFG P/N
6505011717493
NSN
6505-01-171-7493
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 25 MG.; POWDER; ORAL; SOLUBLE; FOR RECONSTITUTION IN WATER
Related Searches:
NDC12870-0001-02
APPLICATOR,SILVER NITRATE
NSN, MFG P/N
6505011717559
NSN
6505-01-171-7559
NDC12870-0001-02
APPLICATOR,SILVER NITRATE
NSN, MFG P/N
6505011717559
NSN
6505-01-171-7559
MFG
ARZOL CHEMICAL CO
Description
(NON-CORE DATA) UNIT PACKAGE QUANTITY: 100
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
Related Searches:
NDC00067-0300-82
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011721054
NSN
6505-01-172-1054
NDC00067-0300-82
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011721054
NSN
6505-01-172-1054
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.5629 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 10.25 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0938 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.71 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID BY RORER PHARMACEUTICALS
Related Searches:
NDC00075-0300-99
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011721054
NSN
6505-01-172-1054
NDC00075-0300-99
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011721054
NSN
6505-01-172-1054
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.5629 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 10.25 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0938 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.71 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID BY RORER PHARMACEUTICALS
Related Searches:
SLO-BID
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011721054
NSN
6505-01-172-1054
SLO-BID
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011721054
NSN
6505-01-172-1054
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.5629 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 10.25 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0938 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.71 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID BY RORER PHARMACEUTICALS
Related Searches:
SLO-BID GYROCAPS
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011721054
NSN
6505-01-172-1054
SLO-BID GYROCAPS
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505011721054
NSN
6505-01-172-1054
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.5629 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 6
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 10.25 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0938 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.71 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
THERAPEUTIC EQUIVALENT: SLO-BID BY RORER PHARMACEUTICALS
Related Searches:
DANOCRINE
DANAZOL CAPSULES,USP
NSN, MFG P/N
6505011721147
NSN
6505-01-172-1147
MFG
SANOFI INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DANAZOL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DANAZOL CAPSULES USP 100MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
